BhavanaBhatnagarDO
Hematology • Wheeling, WVHematologic Oncology, Myeloproliferative Disorder Hematology-Oncology
Associate Professor of Medicine
Dr. Bhatnagar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Medical Park
Wheeling, WV 26003Phone+1 304-243-6442
Education & Training
University of MarylandFellowship, Hematology and Medical Oncology, 2010 - 2013
Cleveland Clinic FoundationResidency, Internal Medicine, 2007 - 2010
Philadelphia College of Osteopathic MedicineClass of 2007
Certifications & Licensure
OH State License 2007 - 2025
WV State License 2021 - 2025- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Aspacytarabine for the treatment of patients with AML unfit for intensive chemotherapy: a phase 2 study.Jessica K Altman, Tsila Zuckerman, Jamie Koprivnikar, James McCloskey, Vamsi Kota
Blood Advances. 2023-12-26 - 1 citationsA phase 2 and pharmacological study of sapanisertib in patients with relapsed and/or refractory acute lymphoblastic leukemia.Aref Al-Kali, Ibrahim Aldoss, Pamela J Atherton, Carrie A Strand, Bijal Shah
Cancer Medicine. 2023-12-01 - 4 citationsPhase 1 study of selinexor in combination with salvage chemotherapy in Adults with relapsed or refractory Acute myeloid leukemia.Bhavana Bhatnagar, Qiuhong Zhao, Alice S Mims, Sumithira Vasu, Gregory K Behbehani
Leukemia & Lymphoma. 2023-12-01
Journal Articles
- Effectiveness of Integrated Palliative and Oncology Care for Patients with Acute Myeloid LeukemiaAreej El-Jawahri, Thomas W Leblanc, Selina M Luger, Bhavana Bhatnagar, Alison R Walker, Amir T Fathi, Andrew M Brunner, Gabriela S Hobbs, Jennifer S Temel, JAMA Oncology
Authored Content
- Consolidation Therapy with Blinatumomab Improves Overall Survival in Newly Diagnosed Adult Patients with B-lineage Acute Lymphoblastic Leukemia in Measurable Residual Disease Negative Remission: Results from the ECOG-ACRIN E1910 Randomized Phase III National Cooperative Clinical Trials Network TrialDecember 2022
Press Mentions
New Providers Join WVU MedicineJune 10th, 2021- The Black-White Gap in Blood Cancer OutcomesFebruary 25th, 2021
- Ohio State Study Suggests Black Patients More Likely to Die of Acute Myeloid LeukemiaFebruary 25th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
